News
From chronic headaches to muscle weakness, know these subtle signs that can signal underlying neurological conditions.
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...
UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.
The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.
Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...
EarlyHumans on MSN1h
Island's Tragic History - Colonization, Disease & Resilience'Kill Bill' And 'Reservoir Dogs' Star Michael Madsen's Cause Of Death Revealed: Reports Videos show water rising within ...
Alzheimer's Association reveals staggering numbers of caregivers in Maryland, facing financial and emotional burdens. Experts offer advice.
Jim Rogers, who lives in Australia, was diagnosed with early-onset Alzheimer's at 55 years old after the seconds-long test ...
Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...
Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results